NVAX R&D Expense Growth
Novavax Inc · R&D Expense Growth
NVAX R&D Expense Growth
Latest reported-13.89%period ending
NVAX FY R&D Growth (YoY) (0.00% → -13.89%)
Latest values, visible window
High-resolution chart · PNG
NVAX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -13.894% | |
| -46.9603% | |
| -40.2967% | |
| -51.2616% | |
| 239.2793% | |
| 556.1963% | |
| -34.4971% | |
| 3.1834% | |
| -29.2108% | |
| 46.2944% | |
| 104.7511% | |
| 57.8974% | |
| 93.0394% | |
| 45.7143% | |
| -36.1979% | |
| 8.7355% | |
| 5.9423% | |
| 38.2614% | |
| 52.6585% | |
| 127.1724% | |
| -31.1304% | |
| -26.7349% | |
| -12.5467% | |
| 6.7378% | |
| 15.1421% | |
| 175.2353% | |
| 0% | |
| 17.2414% | |
| -21.6216% | |
| 0% |